Anti-cd160 specific antibodies for the treatment of eye disorders based on neoangiogenesis

Anti-cd160 specific antibodies for the treatment of eye disorders based on neoangiogenesis

  • CN 102,892,432 A
  • Filed: 05/27/2011
  • Published: 01/23/2013
  • Est. Priority Date: 05/28/2010
  • Status: Active Application
First Claim
Patent Images

1. anti--CD160 antibody is used for the treatment of and/or prevents neogenesis vascular ophthalmopathy.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×